Inventor · disambiguated record
Michael Alistair O'Brien
Also filed as: O'BRIEN MICHAEL A · O'BRIEN MICHAEL ALISTAIR · O’BRIEN MICHAEL
25 granted patents·16 pending applications·345 citations·filing 2004–2024
97Inventor score
Files withASTEX THERAPEUTICS LTD17HEPTARES THERAPEUTICS LTD11BERDINI VALERIO4NXERA PHARMA UK LTD4CHESSARI GIANNI3
Top patents by PatentIndex Score
41 records- 0198US10961225B2Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptorHEPTARES THERAPEUTICS LTD·Filed 2020·Granted Mar 30, 2021·11 cites·16 claims
- 0298US9670183B2Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2015·Granted Jun 6, 2017·34 cites·23 claims
- 0397US10689368B2Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptorHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Jun 23, 2020·12 cites·20 claims
- 0497US10196380B2Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Feb 5, 2019·20 cites·16 claims
- 0596US9926297B2Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Mar 27, 2018·19 cites·18 claims
- 0696US7754725B2Dihydroxyphenyl isoindolymethanonesASTEX THERAPEUTICS LTD·Filed 2007·Granted Jul 13, 2010·22 cites·10 claims
- 0795US10385039B2Bicyclic aza compounds as muscarnic M1 receptor and/or M4 receptor antagonistsHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Aug 20, 2019·13 cites·20 claims
- 0895US8106057B2Dihydroxyphenyl isoindolylmethanonesCHESSARI GIANNI·Filed 2010·Granted Jan 31, 2012·19 cites·7 claims
- 0995US7385059B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2006·Granted Jun 10, 2008·33 cites·20 claims
- 1092US8895745B2Bicyclic heterocyclic compounds as FGFR inhibitorsBERDINI VALERIO·Filed 2007·Granted Nov 25, 2014·33 cites·20 claims
- 1192US8101648B2Hydroxybenzamide derivatives and their use as inhibitors of HSP90CHESSARI GIANNI·Filed 2006·Granted Jan 24, 2012·20 cites·18 claims
- 1291US9593106B2Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2014·Granted Mar 14, 2017·20 cites·12 claims
- 1390US7977477B2Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2004·Granted Jul 12, 2011·35 cites·23 claims
- 1489US10030012B2Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Jul 24, 2018·9 cites·2 claims
- 1589US8530469B2Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90CHESSARI GIANNI·Filed 2011·Granted Sep 10, 2013·11 cites·21 claims
- 1688US7825140B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2007·Granted Nov 2, 2010·7 cites·19 claims
- 1788US7745638B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2007·Granted Jun 29, 2010·8 cites·23 claims
- 1885US8080666B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsBERDINI VALERIO·Filed 2010·Granted Dec 20, 2011·6 cites·19 claims
- 1983US8513276B2Imidazo[1,2-a]pyridine compounds for use in treating cancerBERDINI VALERIO·Filed 2007·Granted Aug 20, 2013·8 cites·16 claims
- 2077US8779147B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsBERDINI VALERIO·Filed 2011·Granted Jul 15, 2014·2 cites·14 claims
- 2176US2025136616A1Cgrp antagonist compoundsNXERA PHARMA UK LTD·Filed 2024·Application pending·0 cites
- 2273US8779132B2Pharmaceutical compoundsCONGREVE MILES STUART·Filed 2007·Granted Jul 15, 2014·3 cites·8 claims
- 2366US9914719B2Hydroxybenzamide derivatives and their use as inhibitors of HSP90ASTEX THERAPEUTICS LTD·Filed 2014·Granted Mar 13, 2018·0 cites·21 claims
- 2465US9051278B23,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulatorsASTEX THERAPEUTICS LTD·Filed 2014·Granted Jun 9, 2015·0 cites·24 claims
- 2564US12227521B2CGRP antagonist compoundsNXERA PHARMA UK LTD·Filed 2020·Granted Feb 18, 2025·0 cites·31 claims
- 2661US2024376070A1Gpr52 modulator compoundsNXERA PHARMA UK LTD·Filed 2022·Application pending·0 cites
- 2756US2023348416A1Gpr52 modulator compoundsHEPTARES THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2855US2024254101A1Gpr52 modulator compoundsHEPTARES THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2955US2014010892A1Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2013·Application pending·0 cites
- 3053US12344621B2CGRP antagonist compoundsNXERA PHARMA UK LTD·Filed 2020·Granted Jul 1, 2025·0 cites·31 claims
- 3152US2008194562A1Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk'sASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 3252US2023002374A1Gpr52 modulator compoundsHEPTARES THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 3352US2008306069A1Pyrazole Derivatives for the Inhibition of CDK'S and GSK'SASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 3451US2011224203A1Benzimidazole derivatives and their use as protein kinase inhibitorsASTEX THERAPEUTICS LTD·Filed 2011·Application pending·0 cites
- 3547US2009215777A1Pyrimidine Derivatives As HSP90 InhibitorsASTEX THERAPEUTICS LTD·Filed 2006·Application pending·0 cites
- 3646US2008312223A1Thiazole And Isothiazole Derivatives That Modulate The Activity Of CDK, GSK And Aurora KinasesASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 3746US2007105900A1Pharmaceutical compoundsATEX THERAPEUTICS LTD·Filed 2004·Application pending·0 cites
- 3846US2008167309A1Pharmaceutical CompoundsASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 3943US2010160324A1Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinasesASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 4042US2008004270A13,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) InhibitorsASTEX THERAPEUTICS LTD·Filed 2005·Application pending·0 cites
- 4139US2014288040A1Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infectionASTEX THERAPEUTICS LTD·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Alistair O'Brien files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →